ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior / Principal Associate Scientist at Strand Therapeutics - ApplyBlast

Senior / Principal Associate Scientist

Strand Therapeutics

2 months ago

Boston, Massachusetts, United States

Onsite

Full Time

Senior

1 applicant

View Job Listing

Apply to 100+ jobs

About this role

The Senior / Principal Associate Scientist will join Strand Therapeutics' mRNA Programming department to design and execute in vitro immunological and cellular assays, develop ex vivo sample processing protocols, and perform flow cytometry and cell-based assays to evaluate RNA LNP therapeutics for oncology and autoimmune diseases. The role involves data collection, analysis, and cross‑functional communication within a fast‑paced, matrix‑based biotech environment.

Responsibilities

Design and execute in vitro immunological and cellular assays
Develop and run multiparameter flow cytometry assays
Analyze data and present results to cross‑functional teams

Skills

Qualifications

B.S. in Biological SciencesM.S. in Biological SciencesB.S. in BioengineeringM.S. in Bioengineering

About Strand Therapeutics

strandtx.com

Headquarters

Boston, Massachusetts, United States

Company Size

51-200 employees

Founded

2017

View Profile

Strand Therapeutics is a clinical-stage biotechnology company developing programmable mRNA therapeutics for solid tumors, blood cancers, and autoimmune diseases. The company's platform addresses core challenges in genetic medicine—targeting, safety, and potency—through proprietary technologies including SignalPath LNPs for tissue-specific delivery, SignalLock RNA for microRNA-based mRNA encryption, and SignalScript RNA for enhanced potency and durability. Its pipeline includes STX-001 for solid tumors, STX-003 for systemic tumor delivery, and STX-005, a pioneering in vivo CAR-T approach for autoimmune diseases and blood cancers.